Clostridium difficile test is cleared for molecular diagnostic platform

11/13/2013 | GenomeWeb Daily News (free registration)

A Clostridium difficile test developed by IntelligentMDx has been cleared by the FDA for use on the Abbott m2000 molecular diagnostic platform. IntelligentMDx said the assay has been shown in analytical reactivity studies to identify 31 strains of C. difficile in tested samples.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR